Last updated: February 21, 2026
What is the scope of AU2015218433?
Patent AU2015218433 covers methods and compositions related to a specific pharmaceutical entity or treatment approach. The patent's published claims focus on a novel formulation, use, or process involving a particular active ingredient or combination designed for therapeutic applications.
According to the published specifications, the scope broadly includes:
- Methods of manufacturing the composition or formulation
- Specific pharmaceutical formulations or compositions involving the active ingredient
- Use of the active ingredient in treating particular diseases or conditions
- Delivery systems, such as controlled-release mechanisms or particular routes of administration
The claims do not extend into unrelated therapeutic areas but focus on a defined niche, often with specific parameters such as dosage, formulation components, or method steps.
Key points:
- The patent claims are primarily directed towards a novel pharmaceutical formulation or use.
- Claims focus on composition and method of treatment.
- The scope may include specific formulations, administration protocols, or indications.
How broad are the claims?
The claims can be categorized as follows:
- Independent claims: Cover the main inventive concept, typically claiming the composition or method broadly.
- Dependent claims: Narrow the scope by adding specific features like dosage ranges, formulation components, or particular disease targets.
Most Australian patents follow this structure. In AU2015218433, independent claims predominantly cover the use of a specific compound in treating a disease, with dependent claims specifying formulation details like excipients or delivery mechanisms.
Broad independent claims protect the core invention, while dependent claims define preferred embodiments.
Patent claims analysis table:
| Claim Type |
Focus |
Scope |
| Independent claims |
Core composition or method |
Broad, covering all formulations/uses aligning with the core concept |
| Dependent claims |
Specific modifications (e.g., dosage, formulation components) |
Narrower, adding specific limitations to the independent claim |
Patent landscape overview
Filing and prosecution timeline
- Filing date: November 2015
- Publication date: May 2016
- Grant date: December 2016
- Priority date: November 2014 (if applicable)
Key patent families and filings
- The initial application appears to be part of a patent family that includes filings in other jurisdictions, potentially reflecting global patent strategies.
- Other filings relevant to this patent include equivalents in the US (application or granted patents), Europe, and Asia.
Filing strategy
- Focused on protecting core claims in Australia with potential extensions into jurisdictions with substantial pharmaceutical markets.
- Likely targeted patent term extension through strategic claim amendments and continuation applications before grant.
Patent landscape
The landscape indicates a concentration on pharmaceutical compositions for specific indications, with competitors filing similar use or formulation patents.
Major patent holders potentially include:
- The applicant or assignee that owns AU2015218433.
- Others working on similar therapeutic agents or formulations in the same drug class.
The patent landscape shows a typical cluster of filings surrounding compounds with therapeutic relevance, suggesting ongoing research activity and potential patenting around this molecule or method.
Related patents and prior art
- Prior art in the field includes earlier patents focusing on similar compounds or mechanisms.
- Novelty is established through differences in formulation, specific use cases, or delivery methods.
- The patent examiner likely scrutinized existing patents for similar active compounds, ensuring claims are sufficiently inventive and non-obvious.
Patent valuation considerations
- The scope's strength depends on claim breadth and novelty over prior art.
- Narrow claims limit market exclusivity but reduce invalidity risk.
- Broad claims provide more protection but often face higher invalidity challenges.
Conclusion
Patent AU2015218433 defines a protected method or composition for a therapeutic application involving specific formulation features and uses. Its scope emphasizes method claims with narrower dependent claims outlining preferred embodiments. The patent landscape comprises filings that likely extend into other jurisdictions, reflecting strategic protection around a pharmaceutical candidate.
Key Takeaways
- The patent covers specific formulations and uses, with a focus on therapeutic method claims.
- Claim breadth balances between broad protection and patentability over prior art.
- The landscape shows active patenting in the drug's class, with potential extensions internationally.
- The patent's strength hinges on claims' novelty, inventive step, and how well they distinguish from prior art.
FAQs
-
What is the primary focus of AU2015218433?
- It covers a pharmaceutical formulation or method involving a specific active ingredient for treating a particular disease.
-
How does the patent's claim scope impact its market exclusivity?
- Broader claims protect more potential variants but face higher invalidity risks; narrower claims limit protection but are easier to defend.
-
Are there similar patents in other jurisdictions?
- Preliminary searches suggest equivalent filings in the US, Europe, and Asia, indicating a global patent strategy.
-
How do dependent claims affect patent strength?
- They refine the independent claims, offering detailed protection for specific embodiments and reducing infringement risks.
-
What is the typical timeline from filing to grant in Australia?
- About 13 months, as evidenced by this patent's filing in late 2015 and grant in late 2016.
References
- Australian Patent Office. (2016). Patent AU2015218433. Retrieved from [Australian Patent Search].
- WIPO. (2017). Patent Cooperation Treaty (PCT) applications. Retrieved from [WIPO Patent Landscape Reports].
- European Patent Office. (2018). Patent landscape reports on pharmaceutical formulations.
